Meniscus Surgery Registry

Meniscus Lesion Clinical Trial

Official title:

Arthroscopic Partial Meniscectomy Registry

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04153643
• Other study ID #: STUDY00003999
• Status: Recruiting
• Start date: November 15, 2019
• Est. completion date: November 15, 2040

Study information

• Verified date: July 2023
• Source: State University of New York at Buffalo
• Contact: Nomi S Weiss-Laxer, PhD
• Phone: 716-881-8904
• Email: nomiweis[@]buffalo.edu
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The purpose of this study is to create a data registry of arthroscopic partial meniscectomies performed at our institution. This information will then be used to examine trends over time, predictive factors, and outcomes of arthroscopic partial meniscectomy.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1000
• Est. completion date: November 15, 2040
• Est. primary completion date: November 15, 2039
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• Scheduled to undergo arthroscopic partial meniscectomy with one of the study investigators at University at Buffalo Medical Doctors Orthopaedics and Sports Medicine

Exclusion Criteria:

• Non-english speaking

Related Conditions & MeSH terms

• Meniscus Lesion

Intervention

Procedure:
• Arthroscopic Partial Meniscectomy
Surgical treatment for meniscus tear

Locations

Country	Name	City	State
United States	UBMD Orthopaedics & Sports Medicine	Amherst	New York

Sponsors (1)

Lead Sponsor	Collaborator
State University of New York at Buffalo

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Knee Pain Score	minimum of 0 (poor function), maximum of 100 (excellent function)	20 years